CVE-2007-1713

Description

CRLF injection vulnerability in BSMTP.DLL in B21Soft BASP21 2003.0211, and BASP21 Pro 1.0.702.27 and earlier, allows remote attackers to inject arbitrary headers into e-mail messages via CRLF sequences in Subject lines.

6.4

CVSS

Severity: Medium

CVSS 2.0 •

EPSS 0.52%

Vendor Advisory secunia.com

Affected: n/a n/a

References

Link	Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/33211	vdb entry
http://www.hi-ho.ne.jp/babaq/basp21.html
http://osvdb.org/34495	vdb entry
http://www.vupen.com/english/advisories/2007/1113	vdb entry
http://www.securityfocus.com/bid/23134	vdb entry
http://jvn.jp/jp/JVN%2386092776/index.html	third party advisory
http://secunia.com/advisories/24652	third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2007-1713?: CVE-2007-1713 has been scored as a medium severity vulnerability.
How to fix CVE-2007-1713?: To fix CVE-2007-1713, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2007-1713 being actively exploited in the wild?: As for now, there are no information to confirm that CVE-2007-1713 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.

This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.